Loading...
•
Dec 31, 2021
Treace Q4 2021 Earnings Report
Treace Medical Concepts reported financial results, showing revenue increase and strategic investments.
Key Takeaways
Treace Medical Concepts reported a strong fourth quarter with a 39% increase in revenue compared to the same period last year, driven by the bunion-focused direct sales channel and direct-to-consumer programs. The company's gross margin also increased to 81.1%.
Revenue of $33.4 million, a 39% increase over the same period last year and a 55% increase sequentially.
Gross margin of 81.1%, an increase of 220 basis points from the same period last year.
Increased strategic investments in sales and marketing programs, including expanded direct sales channel and direct-to-consumer (DTC) campaigns, as well as R&D programs for product innovations.
Fourth quarter revenue contribution from bunion-focused direct sales channel was 58% of sales, an increase from an average of 39% in the fourth quarter 2020.
Forward Guidance
Treace expects revenue for the full year 2022 to range from $125 million to $130 million, which represents approximately 32% to 38% growth over the Company’s 2021 revenue.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...